GENSF Stock: Genus plc Stock Price, Analysis & Insights
Get live GENSF stock price $31.07, comprehensive Genus plc stock analysis, charts, news, and expert forecast. Real-time GENSF stock data and investment insights.
Loading chart data...
Genus plc (GENSF) Overview
Genus plc (GENSF) is a publicly traded company in the Healthcare sector , specifically within the Biotechnology industry . As of the latest trading session, GENSF trades at $31.07 with a market capitalization of 2.06B . Over the past 52 weeks, GENSF has traded between $26.01 and $37.25 , with the current price positioned at approximately 45% of this range . The stock currently trades at a price...
Key Takeaways
- Operates in the Healthcare sector (Biotechnology)
- Market cap: 2.06B
- Current price: $31.07
- 52-week range: $26.01 - $37.25
- P/E ratio: 32.70
Investment Score
A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.
Score unavailable for this asset.
0-39
Defensive posture
40-54
Mixed / wait for confirmation
55-69
Constructive setup
70-100
Attractive zone
Total Score
Value
Cheapness vs fundamentals and cash generation
Quality
Durability of profitability and balance sheet
Momentum
Price trend strength and persistence
Company Overview
Genus plc is a global animal genetics company, with operations extending across North America, Latin America, the United Kingdom, broader Europe, the Middle East, Russia, Africa, and Asia. The firm organizes its business into three primary segments: ...
Company Information
- CEO
- Jorgen Kokke
- Sector
- Healthcare
- Industry
- Biotechnology
- Employees
- 3500
Contact Information
- Website
- https://www.genusplc.com
- Address
- Matrix House
- Country
- GB
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
✓ Growth-oriented company with premium valuation (P/E: 32.7)
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Genus plc shareholders
- ⚠Market volatility can significantly impact stock price, especially for smaller companies
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for Genus plc
- ⚠Investors should consider how Genus plc fits within their overall portfolio allocation
- ⚠Premium valuation (P/E: 32.7) requires strong growth to justify
Market Cap
2.06B
P/E Ratio (TTM)
32.70
Beta
0.90
Data Sources & Methodology
Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.
Related Stocks
Compare GENSF with peer companies:
- Price
- $24.99
- Market cap
- 1.65B
- Price
- $35.00
- Market cap
- 3.11B
- Price
- $0.70
- Market cap
- 1.11B
- Price
- $32.10
- Market cap
- 1.11B
- Price
- $8.67
- Market cap
- 2.02B
- Price
- $1.55
- Market cap
- 2.00B
- Price
- $8.88
- Market cap
- 1.12B
- Price
- $1.70
- Market cap
- 1.65B
- Price
- $106.48
- Market cap
- 1.84B
- Price
- $5.98
- Market cap
- 768.38M
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.